Updated:
UM Ventures
UM Ventures commercializes University of Maryland research, seeding biotech and medical device startups from Baltimore and College Park.
UM Ventures
UM Ventures is an initiative of the University of Maryland that channels technical resources and research expertise. It engages partners in industry and social ventures to expand real-world impact. The initiative provides expert advice and business services to students and faculty, facilitating market entry for discoveries.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Baltimore
Corporate office
Baltimore, MD, United States
Principals
James L. Hughes
Chief Enterprise & Economic Development Officer and Senior Vice President, University of Maryland, Baltimore
Sector focus
Frequently asked questions
How does UM Ventures source its investment opportunities?
Deal flow comes entirely from invention disclosures filed by faculty and researchers at the University of Maryland, Baltimore and the University of Maryland, College Park. A commercialization review board evaluates each disclosure and decides which technologies advance to patent protection and seed funding. The office does not invest in companies without a university-affiliated founder or licensed IP.
Does UM Ventures take equity or only royalty positions in its startups?
UM Ventures typically negotiates an equity stake in newly formed companies in exchange for exclusive licensing rights to the underlying university patents. The office also receives standard royalty structures on commercialized products. Specific equity percentages are negotiated deal by deal and are not publicly disclosed.
Which therapeutic areas does the UM Ventures portfolio concentrate on?
The portfolio skews toward oncology, immunotherapy, infectious disease, neuroscience, and cardiovascular medicine — mirroring the research priorities of the University of Maryland School of Medicine. Medical devices, diagnostics, and health IT also appear, particularly from the bioengineering and computer science departments in College Park.
How is UM Ventures connected to the University of Maryland BioPark?
UM Ventures and the University of Maryland BioPark are separate entities but operationally aligned. The BioPark provides physical wet-lab and office space for portfolio companies, while UM Ventures steers faculty startups into BioPark facilities. Both report into UMB's economic development structure, and the BioPark's tenant pipeline depends significantly on UM Ventures' spinout activity.
Can external investors co-invest alongside UM Ventures in university spinouts?
Yes. UM Ventures frequently syndicates with the Maryland Venture Fund, TEDCO, and regional early-stage firms. The office introduced a co-investor network to match external venture capital with faculty-founded startups. External participation is encouraged as a validation mechanism before the seed round closes.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: